🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
REGN
NASDAQ
🇺🇸 US
Regeneron Pharmaceuticals, Inc.
Pharmaceuticals
39Score
DipBuster Score™
$612.14
+$0.66 (+0.11%)
Live price · Source: Yahoo
52-Week Position
$503.25
34% of range
$821.11
Beta
0.238
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.238
52W High$821.11
52W Low$503.25
🤖
Watch — Score 39/100
Zone: Buy Zone
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position34% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.238
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Regeneron Pharmaceuticals, Inc. free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
26/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
🟡
Watch
DipBuster Score: 39/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeu…
Sector
Pharmaceuticals
Market
🇺🇸 US
CEO
Leonard S. Schleifer
Staff
15,158 employees
Website